Literature DB >> 10764748

Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit.

A P Mould1, J A Askari, M J Humphries.   

Abstract

The NH(2)-terminal portion (putative ligand-binding domain) of alpha subunits contains 7 homologous repeats, the last 3 or 4 of which possess divalent cation binding sequences. These repeats are predicted to form a seven-bladed beta-propeller structure. To map ligand recognition sites on the alpha(5) subunit we have taken the approach of constructing and expressing alpha(V)/alpha(5) chimeras. Although the NH(2)-terminal repeats of alpha(5) and alpha(V) are >50% identical at the amino acid level, alpha(5)beta(1) and alpha(V)beta(1) show marked differences in their ligand binding specificities. Thus: (i) although both integrins recognize the Arg-Gly-Asp (RGD) sequence in fibronectin, the interaction of alpha(5)beta(1) but not of alpha(V)beta(1) with fibronectin is strongly dependent on the "synergy" sequence Pro-His-Ser-Arg-Asn; (ii) alpha(5)beta(1) binds preferentially to RGD peptides in which RGD is followed by Gly-Trp (GW) whereas alpha(V)beta(1) has a broader specificity; (iii) only alpha(5)beta(1) recognizes peptides containing the sequence Arg-Arg-Glu-Thr-Ala-Trp-Ala (RRETAWA). Therefore, amino acid residues involved in ligand recognition by alpha(5)beta(1) can potentially be identified in gain-of-function experiments by their ability to switch the ligand binding properties of alpha(V)beta(1) to those of alpha(5)beta(1). By introducing appropriate restriction enzyme sites, or using site-directed mutagenesis, parts of the NH(2)-terminal repeats of alpha(V) were replaced with the corresponding regions of the alpha(5) subunit. Chimeric subunits were expressed on the surface of Chinese hamster ovary-B2 cells (which lack endogenous alpha(5)) as heterodimers with hamster beta(1). Stable cell lines were generated and tested for their ability to attach to alpha(5)beta(1)-selective ligands. Our results demonstrate that: (a) the first three NH(2)-terminal repeats contain the amino acid sequences that determine ligand binding specificity and the same repeats include the epitopes of function blocking anti-alpha subunit mAbs; (b) the divalent cation-binding sites (in repeats 4-7) do not confer alpha(5)beta(1)- or alpha(V)beta(1)-specific ligand recognition; (c) amino acid residues Ala(107)-Tyr(226) of alpha(5) (corresponding approximately to repeats 2 and 3) are sufficient to change all the ligand binding properties of alpha(V)beta(1) to those of alpha(5)beta(1); (d) swapping a small part of a predicted loop region of alpha(V) with the corresponding region of alpha(5) (Asp(154)-Ala(159)) is sufficient to confer selectivity for RGDGW and the ability to recognize RRETAWA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764748     DOI: 10.1074/jbc.M000572200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Differential regulation of a novel variant of the alpha(6) integrin, alpha(6p).

Authors:  Tracy L Davis; Friederike Buerger; Anne E Cress
Journal:  Cell Growth Differ       Date:  2002-03

2.  Identification of a novel structural variant of the alpha 6 integrin.

Authors:  T L Davis; I Rabinovitz; B W Futscher; M Schnölzer; F Burger; Y Liu; M Kulesz-Martin; A E Cress
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

3.  Osteogenic differentiation of human mesenchymal stem cells synergistically enhanced by biomimetic peptide amphiphiles combined with conditioned medium.

Authors:  Joel M Anderson; Jeremy B Vines; Jessica L Patterson; Haiyan Chen; Amjad Javed; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

4.  Molecular basis of the recognition of nephronectin by integrin alpha8beta1.

Authors:  Yuya Sato; Toshihiko Uemura; Keisuke Morimitsu; Ryoko Sato-Nishiuchi; Ri-Ichiroh Manabe; Junichi Takagi; Masashi Yamada; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

5.  Structure of integrin alpha5beta1 in complex with fibronectin.

Authors:  Junichi Takagi; Konstantin Strokovich; Timothy A Springer; Thomas Walz
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

6.  Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.

Authors:  Zuzana Saidak; Carole Le Henaff; Sofia Azzi; Caroline Marty; Sophie Da Nascimento; Pascal Sonnet; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

7.  Cloning and characterization of chicken α5 integrin: endogenous and experimental expression in early chicken embryos.

Authors:  Yukinori Endo; Hiroko Ishiwata-Endo; Kenneth M Yamada
Journal:  Matrix Biol       Date:  2013-04-13       Impact factor: 11.583

8.  Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation.

Authors:  Zahia Hamidouche; Olivia Fromigué; Jochen Ringe; Thomas Häupl; Pierre J Marie
Journal:  BMC Cell Biol       Date:  2010-06-23       Impact factor: 4.241

9.  An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.

Authors:  Yuya Sato; Tomoya Isaji; Michiko Tajiri; Shumi Yoshida-Yamamoto; Tsuyoshi Yoshinaka; Toshiaki Somehara; Tomohiko Fukuda; Yoshinao Wada; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

10.  Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment.

Authors:  Jian-Ping Xiong; Bhuvaneshwari Mahalingham; Jose Luis Alonso; Laura Ann Borrelli; Xianliang Rui; Saurabh Anand; Bradley T Hyman; Thomas Rysiok; Dirk Müller-Pompalla; Simon L Goodman; M Amin Arnaout
Journal:  J Cell Biol       Date:  2009-08-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.